NPF-Funded Research

Capacity of Electrophilic Fatty Acids to Accumulate in the Skin

Headshot to be 275 x 275 px

Principal Investigator: Alicia Mathers, Ph.D.
Institution: University of Pittsburgh


Grant Mechanism: R01 Bridge Grant
Funding Amount: $100,000
Project Start Date: August 1, 2024
Project End Date: July 31, 2025
Status: Active
Keywords: Psoriasis, Drug Therapy, Inflammation, Diet, Cell Signaling

Project Summary:

Fatty acids in the skin play a pivotal role in maintaining skin integrity. Moreover, fatty acids that have been nitrated (NO2-FAs) exhibit potent anti-inflammatory properties as a natural mechanism to safeguard the skin. Conjugated linoleic acid (CLA) is an essential fatty acid only obtained through dietary supplementation. Importantly, CLA in the skin can lead to the formation of NO2-CLA following UVB phototherapy. Thus, we hypothesize that forming NO2-CLA in the skin by dietary supplementation of CLA along with phototherapy will be an easy-to-adopt therapeutic for psoriasis. Herein, we will address critiques from our NIH proposal concerning the applicability of a proposed humanized mouse model used to test therapies.

How will your project help improve the lives of the 125 million affected by psoriatic disease?

Why is psoriatic disease research important to you, personally? What role will this award play in your research efforts or career development?






Researcher Profile:

Impact of NPF-Funded Research

The NPF has awarded over $30 million in research funding in recent years, with immeasurable impact on our community.

Read more

We Need Your Help

With your gift we can fund even more research to get better treatment and diagnostic options and someday, a cure.

Help fund critical research

NPF-Funded Research

Discover our other active research projects.

Learn more

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2024 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.